SecBot SecBot
8-K ·Filed Apr 14, 2026

VREOF

Vireo Growth Inc.
MIXED
Impact 7/10
Horizonweeks Processed7mo ago SEC0001104659-26-043175
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ◆ Mixed

Traders should monitor the integration of Hawthorne operations and potential margin improvements from supply chain optimization. The significant dilution may pressure the stock short-term, but long-term value depends on successful integration and realization of synergies. Watch for Hagedorn's influence on strategy as the new board nominee.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$13.50
T+0 close · Apr 14, 2026 · via day close
Latest settled
−26.30%
T+60 · $9.95
Vs SPY
−34.43%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 15 $13.50entry
  2. T+1 · 7mo ago −2.89%α −3.13% · $13.11
  3. T+5 · 7mo ago +10.44%α +8.83% · $14.91
  4. T+20 · 6mo ago −7.78%α −13.83% · $12.45
  5. T+60 · 4mo ago −26.30%α −34.43% · $9.95

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Vireo Growth Inc. completed the acquisition of The Hawthorne Gardening Company from Scotts Miracle-Gro, issuing 213 million shares and warrants for 80 million shares. The deal strengthens Vireo's balance sheet with $110 million in cash and net working capital, but the stock will be diluted by approximately 14% immediately and up to 19% if all warrants are exercised.

Key Financial Metrics

EPS
−$0.01
est $0.01 · -200.0%
Revenue
$104.5M
est $109.2M · -4.3% · +317.7% YoY
Rating
strong miss
Gross Margin
54.4%
Deal Value
$127.8M
Deal Type
acquisition
Dilution
14%

Key Facts

  • Acquired The Hawthorne Gardening Company from Scotts Miracle-Gro
  • Issued 213 million shares and warrants for 80 million shares as consideration
  • Deal brings $110 million in cash and net working capital to Vireo
  • Immediate dilution of approximately 14% to existing shareholders
  • Potential dilution up to 19% if all warrants are exercised
  • Nominated Scotts executive Chris Hagedorn for Vireo's Board of Directors

Financial Impact

$110 million in cash and net working capital

cashworking capitaldilution

Risk Factors

  • Dilution from 213 million share issuance and potential 80 million from warrants
  • Integration challenges of Hawthorne operations
  • Dependence on successful realization of supply chain synergies

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-043175
Document: tm2611658d1_ex10-1.htm0001104659-26-043175
Document: tm2611658d1_ex4-1.htm0001104659-26-043175
Document: tm2611658d1_8k.htm0001104659-26-043175
Document: tm2611658d1_ex99-1.htm0001104659-26-043175
Document: 0001104659-26-043175-index-headers.html0001104659-26-043175
Document: 0001104659-26-043175-index.html0001104659-26-043175
8-K Data (Synthetic)0001104659-26-043175

US Market Status

Market Closed · Opens in 6h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 14, 2026